ro5093151
Small moleculeexperimental
Clinical trial activity
5 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
3
Phase 2
2
Phase 3
0
Phase 4
0
Earliest trial started Apr 1, 2009 (NCT00823680)
Timeline
Indications
Mechanism of action
HSD11B1 inhibitor
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- ro5093151
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT02622334 | Phase 1 | Dec 31, 2015 | Roche |
| NCT01493271 | Phase 2 | Dec 1, 2011 | Roche |
| NCT01591850 | Phase 1 | Sep 1, 2011 | Roche |
| NCT01277094 | Phase 1 | Apr 1, 2011 | Roche |
| NCT00823680 | Phase 2 | Apr 1, 2009 | Roche |
Showing 5 of 5 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Roche | For profit | 5 | 5 | 2 | 2009 |
1 organizations
Page 1 / 1